Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27465051)

Published in Support Care Cancer on July 27, 2016

Authors

Devon K Check1, Katherine E Reeder-Hayes2,3, Leah L Zullig4,5, Morris Weinberger6,4, Ethan M Basch6,2,3, Stacie B Dusetzina6,2,7

Author Affiliations

1: Department of Health Policy and Management, , CB#7411, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA. devon.k.check@kp.org.
2: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
3: Division of Hematology/Oncology, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
4: Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC, USA.
5: Department of Medicine, Division of General Internal Medicine, Duke University, Durham, NC, USA.
6: Department of Health Policy and Management, , CB#7411, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
7: Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.

Articles cited by this

A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol (2004) 42.68

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63

Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol (2003) 12.48

American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol (2012) 7.54

Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2011) 7.24

Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med (2003) 6.47

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97

The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med (2003) 4.56

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol (2009) 2.61

Implementing the Institute of Medicine definition of disparities: an application to mental health care. Health Serv Res (2006) 2.52

Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med (2001) 2.42

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol (2005) 2.34

Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med (2005) 2.25

Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat (2003) 2.14

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer (2003) 1.98

Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health Aff (Millwood) (2011) 1.91

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68

Comparing methods of racial and ethnic disparities measurement across different settings of mental health care. Health Serv Res (2010) 1.38

Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med (2004) 1.29

Determinants of participation in treatment decision-making by older breast cancer patients. Breast Cancer Res Treat (2004) 1.24

Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat (2009) 1.23

Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat (2007) 1.16

Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health (2014) 1.10

Cultural competence in oncology: where do we stand? Ann Oncol (2009) 1.03

Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer (2012) 0.99

Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol (2009) 0.99

Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients. Clin Breast Cancer (2005) 0.97

Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer (2014) 0.93

Racial and ethnic disparities in cancer pain management. J Natl Black Nurses Assoc (2009) 0.91

Unequal quality of cancer pain management: disparity in perceived control and proposed solutions. Oncol Nurs Forum (2007) 0.88

Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manage (2014) 0.86

Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks. Cancer (2011) 0.86

Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer. J Med Econ (2013) 0.80

Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study. Ann Surg Oncol (2011) 0.77

Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer. Breast Cancer Res Treat (2016) 0.75